Tega Therapeutics

Glycoscience company developing heparan sulfate therapies and enzyme replacement therapy

placeSan Diego, California, United States calendar_todayFounded 2013 groups7 employees language tegatherapeutics.com

Innovation

4 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 124 times.

YearFilings
20171
20182
20192
20202
20211
20222
20233
20242

Investor mix

3 investors on record.

Investor typeCountShare
Angel & family office133%
Other / undisclosed267%
Coming soon